Smoking and mental health - NCSCT

Neurobiological and behavioural mechanisms linking smoking and mental disorders 3
77 Caldarone BJ, King SL, Picciotto MR. Sex differences in anxiety-like behavior and
locomotor activity following chronic nicotine exposure in mice. Neuroscience Letters
2008;439:187–91.
78 Ouagazzal AM, Kenny PJ, File SE. Modulation of behaviour on trials 1 and 2 in the
elevated plus-maze test of anxiety after systemic and hippocampal administration of
nicotine. Psychopharmacology 1999;144:54–60.
79 Biala G, Budzynska B. Effects of acute and chronic nicotine on elevated plus maze in mice:
involvement of calcium channels. Life Sciences 2006 30;79:81–8.
80 Benwell ME, Balfour DJ. Effects of nicotine administration and its withdrawal on plasma
corticosterone and brain 5-hydroxyindoles. Psychopharmacology 1979;63:7–11.
81 Buczek Y, Le AD, Wang A, Stewart J, Shaham Y. Stress reinstates nicotine seeking but not
sucrose solution seeking in rats. Psychopharmacology 1999;144:183–8.
82 Martin-Garcia E, Barbano MF, Galeote L, Maldonado R. New operant model of nicotineseeking
behaviour in mice. International Journal of Neuropsychopharmacology
2009;12:343–56.
83 Jonkman S, Risbrough VB, Geyer MA, Markou A. Spontaneous nicotine withdrawal
potentiates the effects of stress in rats. Neuropsychopharmacology 2008;33:2131–8.
84 O’Dell LE, Khroyan TV. Rodent models of nicotine reward: what do they tell us about
tobacco abuse in humans? Pharmacology, Biochemistry and Behavior 2009;91:481–8.
85 Kalman D. The subjective effects of nicotine: methodological issues, a review of
experimental studies, and recommendations for future research. Nicotine and Tobacco
Research 2002;4:25–70.
86 Kalman D, Smith SS. Does nicotine do what we think it does? A meta-analytic review of
the subjective effects of nicotine in nasal spray and intravenous studies with smokers and
nonsmokers. Nicotine and Tobacco Research 2005;7:317–33.
87 Salin-Pascual RJ, de la Fuente JR, Galicia-Polo L, Drucker-Colin R. Effects of transderman
nicotine on mood and sleep in nonsmoking major depressed patients. Psychopharmacology
1995;121:476–9.
88 Salin-Pascual RJ, Drucker-Colin R. A novel effect of nicotine on mood and sleep in major
depression. NeuroReport 1998;9:57–60.
89 Salin-Pascual RJ, Rosas M, Jimenez-Genchi A, Rivera-Meza BL, Delgado-Parra V.
Antidepressant effect of transdermal nicotine patches in nonsmoking patients with major
depression. Journal of Clinical Psychiatry 1996;57:387–9.
90 Cox LS, Patten CA, Krahn LE, et al. The effect of nicotine patch therapy on depression in
nonsmokers: a preliminary study. Journal of Addictive Disease 2003;22:75–85.
91 McClernon FJ, Hiott FB, Westman EC, Rose JE, Levin ED. Transdermal nicotine attenuates
depression symptoms in nonsmokers: a double-blind, placebo-controlled trial.
Psychopharmacology 2006;189:125–33.
92 Gilbert DG, Robinson JH, Chamberlin CL, Spielberger CD. Effects of smoking/nicotine on
anxiety, heart rate, and lateralization of EEG during a stressful movie. Psychophysiology
1989;26:311–20.
93 Levin ED, Conners CK, Silva D, Canu W, March J. Effects of chronic nicotine and
methylphenidate in adults with attention deficit/hyperactivity disorder. Experimental and
Clinical Psychopharmacology 2001;9:83–90.
94 Jamner LD, Shapiro D, Jarvik ME. Nicotine reduces the frequency of anger reports in
smokers and nonsmokers with high but not low hostility: an ambulatory study.
Experimental and Clinical Psychopharmacology 1999;7:454–63.
95 Kassel JD, Unrod M. Smoking, anxiety, and attention: support for the role of nicotine in
attentionally mediated anxiolysis. Journal of Abnormal Psychology 2000;109:161–6.
© Royal College of Physicians 2013 57